Screening For GI Cancers: Early Detection Saves Lives

Gastrointestinal (GI) cancers pose a significant health challenge globally, affecting vital organs involved in digestion. In India, the prevalence of GI cancers is escalating, especially in urban areas, attributed to lifestyle changes and environmental factors. These cancers account for a considerable proportion of cancer cases and related deaths, making early detection imperative for better outcomes.

Screening for GI cancers involves the identification of cancer or precancerous conditions before noticeable symptoms manifest. Early detection enables timely intervention, leading to more successful treatment and increased chances of survival. Additionally, screening can prevent some cancers by detecting and removing precursors like colonic polyps that might become cancerous over time.

Various screening tests are available for different GI cancers:

  • Esophageal Cancer: No standard screening test is available for the general population. However, those with Barrett's esophagus (caused by chronic acid reflux) or with a history of chronic alcohol and tobacco use are at higher risk and may benefit from regular endoscopy and biopsies.
  • Stomach Cancer: Upper GI endoscopy is the primary screening method. However, routine screening for stomach cancer in people at average risk is not recommended. Individuals with certain risk factors may consider screening.
  • Liver Cancer: Ultrasound, combined with alpha-fetoprotein (AFP) blood tests, is commonly used for liver cancer screening, especially for those with chronic liver diseases like hepatitis B or C, cirrhosis, or hemochromatosis.
  • Pancreatic Cancer: No standard screening test exists for the general population. Individuals with a family history of pancreatic cancer or specific genetic syndromes may benefit from regular screening using endoscopic ultrasound or MRI.
  • Gallbladder and Bile Duct Cancers: Routine screening is not recommended for the general population. However, certain individuals with risk factors like gallstones or inflammation may benefit from regular ultrasound screening.
  • Small Intestine Cancer: There is no standard screening test for the general population. individuals with certain risk factors may consider screening using CT enterography, capsule endoscopy, or double-balloon enteroscopy.However, people who have certain risk factors such as Crohn’s disease, celiac disease, genetic syndromes like familial adenomatous polyposis (FAP), Peutz-Jeghers syndrome, or Lynch syndrome may benefit from regular screening with computed tomography (CT) enterography, capsule endoscopy, or double-balloon enteroscopy.
  • Colon and Rectal Cancer: Stool tests, colonoscopy, and sigmoidoscopy are common screening methods. Screening is recommended for everyone starting at age 50 or earlier for individuals with specific risk factors.

While screening can be life-saving, it also comes with limitations and risks, such as false results and complications from invasive procedures. Consultation with a doctor is crucial in deciding the most suitable screening options based on personal and family history, risk factors, and individual preferences.

In conclusion, early detection through GI cancer screening can significantly impact patient outcomes, making it a vital tool in the fight against these deadly diseases. By staying proactive and informed about screening options, individuals can take charge of their health and potentially prevent or detect GI cancers at an early, treatable stage.

Dr. Rajesh Kapoor
Department of GI and Hepatopancreatobiliary Surgery
Book an Appointment